These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37103018)

  • 41. The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation versus (C)arpentier Magna-Ease in (A)ortic position.
    Colli A; Marchetto G; Salizzoni S; Rinaldi M; Di Marco L; Pacini D; Di Bartolomeo R; Nicolini F; Gherli T; Agrifoglio M; Borghetti V; Khoury G; De Paolis M; Zoffoli G; Mangino D; Amorim MJ; Manzan E; Zucchetta F; Balduzzi S; Gerosa G
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):478-85. PubMed ID: 25769464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reintervention After Aortic Valve Replacement: Comparison of 3 Aortic Bioprostheses.
    Lam KY; Koene B; Timmermans N; Soliman-Hamad M; van Straten A
    Ann Thorac Surg; 2020 Aug; 110(2):615-621. PubMed ID: 31846642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced Permanent Pacemaker Implantation in Patients With Stentless Freedom SOLO Compared With Stented Perimount Magna Aortic Bioprostheses: A Propensity Score Weighted Analysis.
    Stanger O; Grabherr M; Göber V; Gahl B; Reineke S; Stahel HT; Carrel TP
    Heart Lung Circ; 2021 Mar; 30(3):423-430. PubMed ID: 32800443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Incidence and Reasons for Re-intervention After Aortic Valve Replacement Using the Trifecta Aortic Bioprosthesis.
    Fard A; Mahmood Z; Nair S; Shaikhrezai K; Al-Attar N
    Curr Probl Cardiol; 2023 Jun; 48(6):101125. PubMed ID: 35114295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis.
    Dellgren G; David TE; Raanani E; Armstrong S; Ivanov J; Rakowski H
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):146-54. PubMed ID: 12091820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Structural Valve Degeneration of Trifecta Bioprosthesis.
    Fukuhara S; Shiomi S; Yang B; Kim K; Bolling SF; Haft J; Tang P; Pagani F; Prager RL; Chetcuti S; Grossman PM; Patel HJ; Deeb GM
    Ann Thorac Surg; 2020 Mar; 109(3):720-727. PubMed ID: 31398357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aortic Valve Replacement With Mechanical Valves vs Perimount Bioprostheses in 50- to 69-Year-Old Patients.
    Lu R; Dismorr M; Glaser N; Sartipy U
    JACC Adv; 2023 Jun; 2(4):100359. PubMed ID: 38938255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis.
    Werner P; Coti I; Kaider A; Gritsch J; Mach M; Kocher A; Laufer G; Andreas M
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):416-424. PubMed ID: 34738111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the Carpentier-Edwards Perimount and St. Jude Medical Epic bioprostheses for aortic valve replacement--a retrospective echocardiographic short-term study.
    Goetzenich A; Langebartels G; Christiansen S; Hatam N; Autschbach R; Dohmen G
    J Card Surg; 2009; 24(3):260-4. PubMed ID: 19438778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses.
    Lange R; Alalawi Z; Voss S; Boehm J; Krane M; Vitanova K
    Front Cardiovasc Med; 2021; 8():822893. PubMed ID: 35127875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suture technique does not affect hemodynamic performance of the small supra-annular Trifecta bioprosthesis.
    Ugur M; Byrne JG; Bavaria JE; Cheung A; Petracek M; Groh MA; Suri RM; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1347-51. PubMed ID: 24518226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sutureless Perceval aortic valve in comparison with the stented Carpentier-Edwards Perimount aortic valve.
    König KC; Wahlers T; Scherner M; Wippermann J
    J Heart Valve Dis; 2014 Mar; 23(2):253-8. PubMed ID: 25076560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience.
    Dell'Aquila AM; Schlarb D; Schneider SR; Sindermann JR; Hoffmeier A; Kaleschke G; Martens S; Rukosujew A
    Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):112-5. PubMed ID: 23159508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One-Year Hemodynamic Performance of Three Cardiac Aortic Bioprostheses: A Randomized Comparative Clinical Trial.
    Montero-Cruces L; Carnero-Alcázar M; Reguillo-Lacruz FJ; Cobiella-Carnicer FJ; Pérez-Camargo D; Campelos-Fernández P; Maroto-Castellanos LC
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive hemodynamic performance and frequency of patient-prosthesis mismatch of the St. Jude Medical Trifecta bioprosthetic aortic valve.
    Yadlapati A; Diep J; Barnes MJ; Grogan T; Bethencourt DM; Vorobiof G
    J Heart Valve Dis; 2014 Jul; 23(4):516-23. PubMed ID: 25803979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamics and reverse remodeling associated with Mosaic, Perimount and Trifecta aortic bioprostheses.
    Kalogerakos PD; Kontopodis N; Ioannou CV; Kladou E; Chalkiadakis G; Athanasiou T; Lazopoulos G
    Expert Rev Med Devices; 2019 Aug; 16(8):743-751. PubMed ID: 31318302
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of the Trifecta bioprosthetic valve in patients with low-flow severe aortic stenosis.
    Takaseya T; Oryoji A; Takagi K; Fukuda T; Arinaga K; Hiromatsu S; Tayama E
    Heart Vessels; 2021 Aug; 36(8):1256-1263. PubMed ID: 33586008
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.